Companies / Exagen Inc.

Exagen Inc.

Nasdaq: XGNCIK 1274737VISTA, CAexagen.com

Financials · FY2025

Revenue$66.58M
Net income$-19.95M
Total debt$22.84M
Cash$24.59M
Diluted EPS$-0.93
Shares outstanding24.2M

Ownership

24.2M shares outstanding · as of Jul 30, 2026
4.9%Insiders
Ownership
Insiders4.88%1,182,276
10%+ / strategic10.42%2,523,438
Institutions46.07%11,161,418
Public float38.63%9,358,207

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Aballi JohnCEOPresident and CEO · Director
3.47%839,834
Black Jeffrey G.Chief Financial Officer
1.41%342,442
Kahn Scott DDirector
McKhann ChasDirector
Stokes FrankDirector

Institutional holders 83

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 12, 2026Black Jeffrey G.
Executive
GrantCommon Stock$237.0K+75K
+28.04%
342,442
1.41% of shares
low
Mar 3, 2026Aballi John
CEO
SellCommon Stock$56.8K-16K
-2.23%
687,299
2.84% of shares
low
Feb 24, 2026Aballi John
CEO
SellCommon Stock$41.3K-11K
-1.60%
702,997
2.90% of shares
low
Mar 3, 2026Aballi John
CEO
GrantCommon Stock$7.8K+3K
+0.37%
689,834
2.85% of shares
low
Feb 24, 2026Black Jeffrey G.
Executive
SellCommon Stock$5.7K-2K
-0.59%
267,442
1.10% of shares
low
Feb 27, 2026Black Jeffrey G.
Executive
GrantCommon Stock$4.6K+2K
+0.44%
343,953
1.42% of shares
low
Mar 12, 2026Aballi John
CEO
GrantCommon Stock$0+150K
+21.74%
839,834
3.47% of shares
low
Jun 9, 2026Stokes Frank
Director
GrantStock Option(right to buy)+38K
+50.00%
112,500
0.46% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
NMSIC Co-Investment Fund, L.P.Passive13G/A
RTW Investments, LPPassive13G/A
Chernett JoreyPassive13G1,231,438
Chernett JoreyPassive13G/A
Parian Ultreia LPPassive13G1,292,000

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
XGN30068X103